lovastatin has been researched along with Schizophrenia in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akhondzadeh, S; Berk, M; Dehbozorgi, S; Ghanizadeh, A; Rezaee, Z | 1 |
Dimitri, E; Landry, P; Légaré, N; Tessier, S | 1 |
Champion, KM; Furst, BA; Pierre, JM; Wirshing, DA; Wirshing, WC | 1 |
1 trial(s) available for lovastatin and Schizophrenia
Article | Year |
---|---|
Lovastatin for the adjunctive treatment of schizophrenia: a preliminary randomized double-blind placebo-controlled trial.
Topics: Adult; Antipsychotic Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Lovastatin; Male; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Treatment Outcome | 2014 |
2 other study(ies) available for lovastatin and Schizophrenia
Article | Year |
---|---|
Efficacy of lipid-lowering medications in patients treated with clozapine: a naturalistic study.
Topics: Adult; Antipsychotic Agents; Atorvastatin; Cholesterol; Clozapine; Female; Fenofibrate; Gemfibrozil; Heptanoic Acids; Humans; Hyperlipidemias; Hypolipidemic Agents; Lovastatin; Male; Middle Aged; Pravastatin; Psychotic Disorders; Pyrroles; Retrospective Studies; Schizophrenia; Treatment Outcome; Triglycerides | 2008 |
Possible association of QTc interval prolongation with co-administration of quetiapine and lovastatin.
Topics: Anticholesteremic Agents; Antipsychotic Agents; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dibenzothiazepines; Electrocardiography; Female; Humans; Hyperlipidemias; Long QT Syndrome; Lovastatin; Middle Aged; Mixed Function Oxygenases; Quetiapine Fumarate; Schizophrenia; Time Factors; Triglycerides | 2002 |